Immediate Impact
1 from Science/Nature 39 standout
Citing Papers
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
2025 Standout
Radiopharmaceuticals and their applications in medicine
2025 Standout
Works of Suhas Singla being referenced
Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma
2016
Dosimetric analysis of 177Lu-DOTA-rituximab in patients with relapsed/refractory non-Hodgkin’s lymphoma
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Suhas Singla | 102 | 32 | 168 | 94 | 34 | 297 | |
| Giulia Santo | 63 | 41 | 113 | 97 | 38 | 269 | |
| Yuntai Cao | 91 | 22 | 209 | 57 | 35 | 287 | |
| Dhanapathi Halanaik | 45 | 32 | 57 | 85 | 27 | 271 | |
| Rajender Kumar Basher | 41 | 14 | 97 | 94 | 43 | 257 | |
| Jules Zhang-Yin | 38 | 11 | 97 | 69 | 32 | 219 | |
| Priyanka Verma | 33 | 15 | 102 | 54 | 41 | 262 | |
| Mio Sakai | 46 | 16 | 127 | 64 | 38 | 313 | |
| June Key Chung | 40 | 74 | 113 | 40 | 29 | 321 | |
| Young-Rok Do | 69 | 59 | 85 | 70 | 37 | 322 | |
| P. Razola | 87 | 47 | 95 | 81 | 57 | 287 |
All Works
Loading papers...